With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone’s prescription-only status. This would make it easier to get the lifesaving drug to people at risk. Read the Full Article.
Recent Posts
- Join NJ ACTS Special Populations Core Seminar Series on 4/30 at 1pm
- NJACTS Community Engagement Core COVID-19 Resources
- Long-Acting Opioids May Be Unnecessary in Study of Total Knee Replacement.
- Predicting Loneliness Through Online Digital Footprints.
- $265K Awarded to NJIT Researchers Via New Jersey Health Foundation Grants.
Categories
- News (2,125)
- Publication (1)